Adam E Robison is a Westmont, Illinois based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. His current practice location is 422 N Cass Ave, Westmont. Patients can book an appointment with him at 630-682-7400.
Adam E Robison is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. He helps his clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Adam E Robison speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Adam E Robison
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Male
Credentials:
CADC
Accepts Medicare Assignment:
No
Practice Address:
422 N Cass Ave, Westmont, Illinois, 60559-1502
Phone:
630-682-7400
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1073401246
NPI Enumeration Date:
26 Jun, 2025
NPI Last Update On:
26 Jun, 2025
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
111 N County Farm Rd, Wheaton, Illinois
Zip:
60187-3988
Patients can reach Adam E Robison at 422 N Cass Ave, Westmont, Illinois or can call to book an appointment on 630-682-7400. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.